Scott Orr, MD
Orthopaedic Surgery · Birmingham, ALNPI 1326380684
Payments from drug & device makers
Across 62 payments — averaging $264.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$11K
- Zimmer Biomet$4K
- Pacira Pharmaceuticals Incorporated$630
- Johnson & Johnson$235
- DJO, LLC$101
- Dynasplint Systems Inc.$96
- plus $439 from 11 others
What the payments were for
- Consulting fees$10,20062%
- Travel & lodging$4,05025%
- Food & beverage$2,12913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 4 | $11,275 |
| Zimmer Biomet | 17 | $3,604 |
| Pacira Pharmaceuticals Incorporated | 11 | $630 |
| Johnson & Johnson(3 entities) | 9 | $235 |
| DJO, LLC | 1 | $101 |
| Dynasplint Systems Inc. | 1 | $96 |
| Aesculap Implant Systems, LLC | 1 | $79 |
| Orthalign Inc | 1 | $70 |
| Abbott | 4 | $63 |
| Bioventus LLC | 3 | $48 |
| Smith+Nephew | 2 | $40 |
| Pacira Therapeutics, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Heraeus Medical, LLC. | 1 | $24 |
| Stryker | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$11,253
- Arcos$2,568
- Iovera$474
- Persona$381
- mymobility Platform$245
- DONJOY$101
How this compares
$16,379 in reported general payments places this provider in the 75th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,645 |
| Celecoxib | 210 | $6,820 |
| Pregabalin | 319 | $6,187 |
| Methocarbamol | 315 | $2,585 |
| Naproxen Sodium | 31 | $2,108 |
| Cefadroxil | 244 | $1,923 |
| Oxycodone Hcl | 308 | $1,715 |
| Tramadol Hcl | 566 | $1,581 |
| Diclofenac Sodium | 111 | $1,429 |
| Methylprednisolone | 156 | $1,408 |
| Gabapentin | 150 | $1,055 |
| Tranexamic Acid | 43 | $1,036 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $618 |
| Meloxicam | 69 | $292 |
| Ibuprofen | 17 | $268 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Birmingham
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- Herrick SiegelBirmingham$1.3M
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$219K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
- Richard SandersBirmingham$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.